02:10 PM EST, 02/13/2025 (MT Newswires) -- Evolus ( EOLS ) said Thursday it received approval from the US Food and Drug Administration for Evolysse Form and Evolysse Smooth injectable hyaluronic acid gels.
The beauty company said it intends to launch the products in the US market in Q2. It plans to launch Evolysse Sculpt in 2026 and Evolysse Lips in 2027.
Shares of the company were up over 6% in recent trading.
Price: 15.22, Change: +0.96, Percent Change: +6.73